These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23891623)

  • 1. Cilostazol improves the response to ischemia in diabetic mice by a mechanism dependent on PPARγ.
    Biscetti F; Pecorini G; Arena V; Stigliano E; Angelini F; Ghirlanda G; Ferraccioli G; Flex A
    Mol Cell Endocrinol; 2013 Dec; 381(1-2):80-7. PubMed ID: 23891623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cilostazol promotes angiogenesis after peripheral ischemia through a VEGF-dependent mechanism.
    Biscetti F; Pecorini G; Straface G; Arena V; Stigliano E; Rutella S; Locatelli F; Angelini F; Ghirlanda G; Flex A
    Int J Cardiol; 2013 Aug; 167(3):910-6. PubMed ID: 22473072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of Angiogenesis by a Type III Phosphodiesterase Inhibitor, Cilostazol, Through Activation of Peroxisome Proliferator-Activated Receptor-γ and cAMP Pathways in Vascular Cells.
    Sanada F; Kanbara Y; Taniyama Y; Otsu R; Carracedo M; Ikeda-Iwabu Y; Muratsu J; Sugimoto K; Yamamoto K; Rakugi H; Morishita R
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):545-52. PubMed ID: 26769045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-derived growth factor C promotes revascularization in ischemic limbs of diabetic mice.
    Moriya J; Wu X; Zavala-Solorio J; Ross J; Liang XH; Ferrara N
    J Vasc Surg; 2014 May; 59(5):1402-9.e1-4. PubMed ID: 23856609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cilostazol improves high glucose-induced impaired angiogenesis in human endothelial progenitor cells and vascular endothelial cells as well as enhances vasculoangiogenesis in hyperglycemic mice mediated by the adenosine monophosphate-activated protein kinase pathway.
    Tseng SY; Chao TH; Li YH; Liu PY; Lee CH; Cho CL; Wu HL; Chen JH
    J Vasc Surg; 2016 Apr; 63(4):1051-62.e3. PubMed ID: 25595409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cilostazol stimulates revascularisation in response to ischaemia via an eNOS-dependent mechanism.
    Hori A; Shibata R; Morisaki K; Murohara T; Komori K
    Eur J Vasc Endovasc Surg; 2012 Jan; 43(1):62-5. PubMed ID: 21852163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic mice.
    Huang PH; Sata M; Nishimatsu H; Sumi M; Hirata Y; Nagai R
    Biomed Pharmacother; 2008 Jan; 62(1):46-52. PubMed ID: 17692499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle-mediated delivery of pioglitazone enhances therapeutic neovascularization in a murine model of hindlimb ischemia.
    Nagahama R; Matoba T; Nakano K; Kim-Mitsuyama S; Sunagawa K; Egashira K
    Arterioscler Thromb Vasc Biol; 2012 Oct; 32(10):2427-34. PubMed ID: 22879581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Diallyl Trisulfide on Ischemic Tissue Injury and Revascularization in a Diabetic Mouse Model.
    Yang HB; Liu HM; Yan JC; Lu ZY
    J Cardiovasc Pharmacol; 2018 Jun; 71(6):367-374. PubMed ID: 29642134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway.
    Sahara M; Sata M; Morita T; Nakajima T; Hirata Y; Nagai R
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1315-24. PubMed ID: 20413734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of serotonin in angiogenesis: induction of angiogenesis by sarpogrelate via endothelial 5-HT1B/Akt/eNOS pathway in diabetic mice.
    Iwabayashi M; Taniyama Y; Sanada F; Azuma J; Iekushi K; Kusunoki H; Chatterjee A; Okayama K; Rakugi H; Morishita R
    Atherosclerosis; 2012 Feb; 220(2):337-42. PubMed ID: 22172591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenic peptides improve blood flow and promote capillary growth in a diabetic and ischaemic mouse model.
    Raiter A; Bechor Z; Kleiman M; Leshem-Lev D; Battler A; Hardy B
    Eur J Vasc Endovasc Surg; 2010 Sep; 40(3):381-8. PubMed ID: 20226697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naoxintong restores collateral blood flow in a murine model of hindlimb ischemia through PPARδ-dependent mechanism.
    Chen L; Zhang L; Fang Z; Li C; Yang Y; You X; Song M; Coffie J; Zhang L; Gao X; Wang H
    J Ethnopharmacol; 2018 Dec; 227():121-130. PubMed ID: 30170078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of fenofibrate in restoring angiogenesis in diabetic and control hind limb ischemic rats.
    Salehi E; Khazaei M; Rashidi B
    Gen Physiol Biophys; 2012 Sep; 31(3):255-60. PubMed ID: 23047938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cilostazol ameliorates metabolic abnormalities with suppression of proinflammatory markers in a db/db mouse model of type 2 diabetes via activation of peroxisome proliferator-activated receptor gamma transcription.
    Park SY; Shin HK; Lee JH; Kim CD; Lee WS; Rhim BY; Hong KW
    J Pharmacol Exp Ther; 2009 May; 329(2):571-9. PubMed ID: 19221061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone enhances collateral blood flow in ischemic hindlimb of diabetic mice through an Akt-dependent VEGF-mediated mechanism, regardless of PPARgamma stimulation.
    Biscetti F; Straface G; Arena V; Stigliano E; Pecorini G; Rizzo P; De Angelis G; Iuliano L; Ghirlanda G; Flex A
    Cardiovasc Diabetol; 2009 Sep; 8():49. PubMed ID: 19737384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin pretreatment enhances ischemia-induced neovascularization and blood flow recovery in streptozotocin-treated mice.
    Huang PH; Chen JY; Chen CY; Chen JW; Lin SJ; Shih CC
    J Vasc Surg; 2016 Oct; 64(4):1112-1120.e1. PubMed ID: 26830691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinin receptor agonism restores hindlimb postischemic neovascularization capacity in diabetic mice.
    Desposito D; Potier L; Chollet C; Gobeil F; Roussel R; Alhenc-Gelas F; Bouby N; Waeckel L
    J Pharmacol Exp Ther; 2015 Feb; 352(2):218-26. PubMed ID: 25398240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
    Li Y; Hazarika S; Xie D; Pippen AM; Kontos CD; Annex BH
    Diabetes; 2007 Mar; 56(3):656-65. PubMed ID: 17327433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: roles of endothelial nitric oxide synthase and endothelial progenitor cells.
    Yan J; Tie G; Park B; Yan Y; Nowicki PT; Messina LM
    J Vasc Surg; 2009 Dec; 50(6):1412-22. PubMed ID: 19837544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.